Mandate to record gift payments to doctors delayed; FDA issues rule on reporting med manufacturing interruptions;

@FiercePharma: Covidien plans to spin off pharma division into a separate company to better compete in the pain-management area. News | Follow @FiercePharma

> A requirement for U.S. drugmakers and device companies to record all payments and gifts to doctors above $10 has been delayed until sometime in 2012. Story

> The FDA has issued an interim final rule requiring manufacturers to report interruptions in production of critical drugs. Release

> Spectrum Pharmaceuticals is generating a significant surge in revenue by developing and marketing neglected cancer drugs it acquires from other companies. Story

> UPS ($UPS) is hoping to cash in on the growing pharma logistics market as expiring patents on big meds like Lipitor push up demand for generic exports from Asia. News

> Investors at Swiss orthopedics maker Synthes overwhelmingly voted to back Johnson & Johnson's $21.3 billion offer to buy the company. Story

Biotech News

@FierceBiotech: Interesting model: Spectrum Pharma spinning gold from other companies' failures. Story | Follow @FierceBiotech

@JohnCFierce: BioSante is getting blasted on the failed libido gel study. Blames the dread placebo effect. Article | Follow @JohnCFierce

> Vertex CEO stepping down after banner year. More

> BioSante shares nosedive after libido gel flunks pivotal studies. News

> Ipsen plans new hires, $45M R&D expansion as it relocates U.S. HQ. Item

> Cerulean garners $15M for PhII lung cancer study. Article

> Third Rock provides $34M bankroll for an obesity/diabetes startup. Piece

Vaccine News

> Preclinical vaccine shrinks tumors 80%. Story

> Novartis opens doors to $1B vaccine plant. Article

> GE jumps in to biologics, vaccine manufacturing game. More

> Antigen Express vaccine cuts breast cancer recurrence. News

Pharma Manufacturing News

> Watch for pharma/carmaker collaboration pitfalls. More

> J&J releases Doxil batch; Ben Venue troubles detailed in FDA report. Article

> Novartis, HHS unveil pandemic-ready vax plant. Item

> Study finds substandard drugs cheaper than fakes. News

> Forecast: Pharma wants CMO consulting, regulatory support. Report

And Finally... Are you shy? Well, there could be help. A new study from Concordia University that will be published in the journal Psychopharmacology has found that a form of intranasal oxytocin spray can smooth awkward social encounters. Article

Suggested Articles

After Purdue’s record opioid settlement, more deals could be on the way. But that doesn’t mean all defendants are prepared to go quietly.

Now in their third quarter on the market, Gilead's own Epclusa and Harvoni generics have together grabbed more than 20% of the U.S. hep C market.

Purdue is seeking bankruptcy after inking a $10 billion-plus opioid settlement with thousands of cities and counties, plus two dozen states.